Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00888992 · ClinicalTrials.gov registry record · NA
Technology-Enhanced Quitline Services to Prevent Smoking Relapse
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 1,785
- Enrollment target
NCT00888992 is a NA study that has completed, run by Indiana University. The registered enrollment target is 1,785 participants.
The verdict
NCT00888992, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,785 participants
- Enrollment target
Study Summary
The purpose of this study is to see if automated telephone monitoring will enhance existing quitline services, such as Alere Wellbeing's Quit For Life program, and help people quit smoking. If successful, this intervention could be incorporated into existing quitline protocols and delivered to millions of people who are trying to quit smoking.
Interventions
- BEHAVIORAL Quitline Service + 10 automated monitoring calls
- BEHAVIORAL Quitline service + 20 automated monitoring calls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,785 participants |
| Start Date | 2010-04 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00888992
The ClinicalTrials.gov registry entry for NCT00888992 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,785 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quitline Service + 10 automated monitoring calls is the first listed.
NCT00888992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00888992 about?
NCT00888992 is a clinical study titled "Technology-Enhanced Quitline Services to Prevent Smoking Relapse". The purpose of this study is to see if automated telephone monitoring will enhance existing quitline services, such as Alere Wellbeing's Quit For Life program, and help people quit smoking. If successful, this intervention could be incorporated into existing quitline protocols and delivered to milli...
What is the current status of trial NCT00888992?
This trial is currently completed. It is a NA study. The enrollment target is 1,785 participants. The study started on 2010-04. Estimated completion is 2014-03.
What interventions are being tested in trial NCT00888992?
The interventions under investigation include: Quitline Service + 10 automated monitoring calls (BEHAVIORAL), Quitline service + 20 automated monitoring calls (BEHAVIORAL).
Who is sponsoring clinical trial NCT00888992?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.